Evidence map›Paper›PMID 32196124›Full record

ArticleHematological oncology2020

Good prognosis for follicular lymphoma with estrogen receptor α-positive follicular dendritic cells.

Rintaro Ohe, Hong-Xue Meng, Akane Yamada, Naing Ye Aung, Takanobu Kabasawa, Yuka Tamura, Aya Utsunomiya, Nobuyuki Tamazawa, Ichiro Kawamura, Takumi Kitaoka and 5 more

Open access · hybridAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Hematological oncology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 1 pooled it
0.3field-weighted citation impact, top 45% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 1 synthesis or guideline pooled it, 7 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Lymphoid stroma in all its states.Frontiers in immunology · 2025
    Review
  4. Review
  5. Review
  6. Review
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 2 institutions in 2 countries.

Rintaro OheDepartment of Pathological Diagnostics, Yamagata University Faculty of Medicine, Yamagata, Japan.ORCID https://orcid.org/0000-0002-8035-791X
Hong-Xue MengDepartment of Pathology, Harbin Medical University Cancer Hospital, Harbin, China.
Akane YamadaDepartment of Neurology, Hematology, Metabolism, Endocrinology and Diabetology, Yamagata University Faculty of Medicine, Yamagata, Japan.
Naing Ye AungDepartment of Pathological Diagnostics, Yamagata University Faculty of Medicine, Yamagata, Japan.
Takanobu KabasawaDepartment of Pathological Diagnostics, Yamagata University Faculty of Medicine, Yamagata, Japan.
Yuka TamuraDepartment of Pathological Diagnostics, Yamagata University Faculty of Medicine, Yamagata, Japan.
Aya UtsunomiyaDepartment of Pathological Diagnostics, Yamagata University Faculty of Medicine, Yamagata, Japan.
Nobuyuki TamazawaDepartment of Pathological Diagnostics, Yamagata University Faculty of Medicine, Yamagata, Japan.
Ichiro KawamuraDepartment of Pathological Diagnostics, Yamagata University Faculty of Medicine, Yamagata, Japan.
Takumi KitaokaDepartment of Pathological Diagnostics, Yamagata University Faculty of Medicine, Yamagata, Japan.
Kazushi SuzukiDepartment of Pathological Diagnostics, Yamagata University Faculty of Medicine, Yamagata, Japan.
Ryo YanagiyaDepartment of Neurology, Hematology, Metabolism, Endocrinology and Diabetology, Yamagata University Faculty of Medicine, Yamagata, Japan.
Tomomi ToubaiDepartment of Neurology, Hematology, Metabolism, Endocrinology and Diabetology, Yamagata University Faculty of Medicine, Yamagata, Japan.
Kenichi IshizawaDepartment of Neurology, Hematology, Metabolism, Endocrinology and Diabetology, Yamagata University Faculty of Medicine, Yamagata, Japan.
Mitsunori YamakawaDepartment of Pathological Diagnostics, Yamagata University Faculty of Medicine, Yamagata, Japan.
Yamagata University · JPHarbin Medical University · CN

Funding

Japan Society for the Promotion of Science JP17K08736Japan Society for the Promotion of Science JP19K16577
6 · The paper itself

Abstract

Follicular lymphoma (FL) has a meshwork of follicular dendritic cells (FDCs). We previously demonstrated the presence of estrogen receptor alpha (ERα)

Indexed as

Tumor MicroenvironmentAdultAgedAged, 80 and overBiomarkers, TumorDendritic Cells, FollicularEstrogen Receptor alphaFemaleFollow-Up StudiesHumansImmunohistochemistryIn Situ HybridizationLymphoma, FollicularMaleMiddle AgedPrognosisBiomarkers, TumorESR1 protein, humanEstrogen Receptor alphaestrogen receptor alphaFLIPIfollicular dendritic cellfollicular lymphomaPrognosis

Identifiers

PMID32196124
PMCPMC7496718
OpenAlexW3012240068

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.